Exosomes + Microneedling for Male Pattern Baldness
Trial Summary
Do I need to stop my current medications for the trial?
The trial requires that you have not taken any medications or treatments for hair loss in the last six months. If you are currently on such treatments, you would need to stop them to participate.
What data supports the effectiveness of the treatment AGE ZERO™ EXOSOMES for male pattern baldness?
Research suggests that exosomes, which are tiny particles derived from cells, can promote hair growth by activating hair follicle cells and encouraging the hair growth cycle. Studies have shown that exosomes from sources like bovine colostrum can help hair regrow in a way similar to existing treatments like minoxidil, without causing skin irritation.12345
Is the combination of exosomes and microneedling safe for treating hair loss?
Research on exosomes and microneedling for hair loss suggests they are generally safe, with studies showing no significant adverse effects like skin rashes when using exosomes derived from bovine colostrum. Microneedling has been used to enhance drug delivery with reduced side effects compared to traditional methods.13678
How does the treatment Exosomes + Microneedling for Male Pattern Baldness differ from other treatments?
This treatment is unique because it combines exosomes, which are tiny particles that can promote hair growth by activating hair follicle cells, with microneedling, a technique that creates tiny punctures in the skin to enhance absorption and stimulate hair growth. Unlike traditional treatments like minoxidil or finasteride, this approach uses a novel mechanism to potentially improve hair regeneration.123910
What is the purpose of this trial?
The purpose of this study is to determine whether Wharton's Jelly mesenchymal stem cell-derived exosome microneedling on the scalp is an effective treatment for Androgenetic Alopecia (pattern hair loss).
Research Team
Eyal K Levit, M.D.
Principal Investigator
Owner and chief physician
Eligibility Criteria
This trial is for men and women with Androgenetic Alopecia, which includes male pattern baldness and alopecia areata. Participants should be looking for treatment options.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive topical applications of WJMSC-exosomes and microneedling in 4 sessions over 4 months
Follow-up
Participants are monitored for changes in hair growth and adverse events
Treatment Details
Interventions
- AGE ZERO™ EXOSOMES
Find a Clinic Near You
Who Is Running the Clinical Trial?
Levit Dermatology
Lead Sponsor
Dorisca Research Consulting, LLC
Collaborator
ResilielleTM Age ZeroTM Exosomes
Collaborator